|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 11 (December 1), 1998:
pp. 4138-4149
Selective Sp1 Binding Is Critical for Maximal Activity of the
Human c-kit Promoter
Gyeong H. Park,
Howard K. Plummer III, and
Geoffrey W. Krystal
From the Division of Hematology/Oncology, Departments of Medicine and
Microbiology/Immunology, Medical College of Virginia/Virginia
Commonwealth University and McGuire VA Medical Center, Richmond, VA.
The receptor tyrosine kinase c-kit is necessary
for normal hematopoiesis, the development of germ cells and
melanocytes, and the pathogenesis of certain hematologic and
nonhematologic malignancies. To better understand the regulation of the
c-kit gene, a detailed analysis of the core promoter was
performed. Rapid amplification of cDNA ends (RACE) and
RNase protection methods showed two major transcriptional initiation
sites. Luciferase reporter assays using 5 promoter
deletion-reporter constructs containing up to 3 kb of 5 sequence
were performed in hematopoietic and small-cell lung cancer cell lines
which either did or did not express the endogenous c-kit gene.
This analysis showed the region 83 to 124 bp upstream of the 5
transcription initiation site was crucial for maximal core promoter
activity. Sequence analysis showed several potential Sp1 binding sites
within this highly GC-rich region. Gel shift and DNase
footprinting showed that Sp1 selectively bound to a single site within
this region. Supershift studies using an anti-Sp1 antibody confirmed
specific Sp1 binding. Site-directed mutagenesis of the  93/84 Sp1
binding site reduced promoter-reporter activity to basal levels in
c-kit-expressing cells. Cotransfection into Drosophila
SL2 cells of a c-kit promoter-reporter construct with an Sp1
expression vector showed an Sp1 dose-dependent enhancement of
expression that was markedly attenuated by mutation of the 93/84
site. These results indicate that despite the fact that the human
c-kit promoter contains multiple potential Sp1 sites, Sp1
binding is a selective process that is essential for core promoter
activity.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Mithraprabhu and K. L Loveland
Control of KIT signalling in male germ cells: what can we learn from other systems?
Reproduction,
November 1, 2009;
138(5):
743 - 757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Todd, S. M. Haider, G. N. Parkinson, and S. Neidle
Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter
Nucleic Acids Res.,
September 27, 2007;
35(17):
5799 - 5808.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Litz and G. W. Krystal
Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1{alpha} activity and vascular endothelial growth factor expression in small cell lung cancer cells.
Mol. Cancer Ther.,
June 1, 2006;
5(6):
1415 - 1422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Thomas, D.-Y. Sung, J. Yang, K. Johnson, W. Thompson, C. Millette, J. McCarrey, A. Breitberg, R. Gibbs, and W. Walker
Identification, Characterization, and Functional Analysis of Sp1 Transcript Variants Expressed in Germ Cells During Mouse Spermatogenesis
Biol Reprod,
April 1, 2005;
72(4):
898 - 907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Lecuyer, S. Herblot, M. Saint-Denis, R. Martin, C. G. Begley, C. Porcher, S. H. Orkin, and T. Hoang
The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1
Blood,
September 18, 2002;
100(7):
2430 - 2440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I.-s. Lee, M. K. Kim, E. Y. Choi, A. Mehl, K. C. Jung, M. C. Gil, M. Rowe, and S. H. Park
CD99 expression is positively regulated by Sp1 and is negatively regulated by Epstein-Barr virus latent membrane protein 1 through nuclear factor-{kappa}B
Blood,
June 1, 2001;
97(11):
3596 - 3604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Vitelli, G. Condorelli, V. Lulli, T. Hoang, L. Luchetti, C. M. Croce, and C. Peschle
A Pentamer Transcriptional Complex Including tal-1 and Retinoblastoma Protein Downmodulates c-kit Expression in Normal Erythroblasts
Mol. Cell. Biol.,
July 15, 2000;
20(14):
5330 - 5342.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. Bondzi, J. Litz, P. Dent, and G. W. Krystal
Src Family Kinase Activity Is Required for Kit-mediated Mitogen-activated Protein (MAP) Kinase Activation, However Loss of Functional Retinoblastoma Protein Makes MAP Kinase Activation Unnecessary for Growth of Small Cell Lung Cancer Cells
Cell Growth Differ.,
June 1, 2000;
11(6):
305 - 314.
[Abstract]
[Full Text]
|
|
|
|
|
